[HTML][HTML] Multifaceted role of the urokinase-type plasminogen activator (uPA) and its receptor (uPAR): diagnostic, prognostic, and therapeutic applications

N Mahmood, C Mihalcioiu, SA Rabbani - Frontiers in oncology, 2018 - frontiersin.org
The plasminogen activator (PA) system is an extracellular proteolytic enzyme system
associated with various physiological and pathophysiological processes. A large body of …

Therapeutics targeting the fibrinolytic system

H Lin, L Xu, S Yu, W Hong, M Huang… - Experimental & molecular …, 2020 - nature.com
The function of the fibrinolytic system was first identified to dissolve fibrin to maintain
vascular patency. Connections between the fibrinolytic system and many other physiological …

Plasmin and plasminogen system in the tumor microenvironment: implications for cancer diagnosis, prognosis, and therapy

AG Bharadwaj, RW Holloway, VA Miller, DM Waisman - Cancers, 2021 - mdpi.com
Simple Summary In this review, we present a detailed discussion of how the plasminogen-
activation system is utilized by tumor cells in their unrelenting attack on the tissues …

The urokinase plasminogen activator system: a target for anti-cancer therapy

S Ulisse, E Baldini, S Sorrenti… - Current cancer drug …, 2009 - ingentaconnect.com
The urokinase plasminogen activator (uPA) system (uPAS) consists of the uPA, its cognate
receptor (uPAR) and two specific inhibitors, the plasminogen activator inhibitor 1 (PAI-1) and …

Involvement of urokinase‐type plasminogen activator system in cancer: An overview

AH Mekkawy, MH Pourgholami… - Medicinal research …, 2014 - Wiley Online Library
Currently, there are several studies supporting the role of urokinase‐type plasminogen
activator (uPA) system in cancer. The association of uPA to its receptor triggers the …

The urokinase receptor (uPAR) as a “Trojan Horse” in targeted cancer therapy: challenges and opportunities

V Metrangolo, M Ploug, LH Engelholm - Cancers, 2021 - mdpi.com
Simple Summary Discovered more than three decades ago, the urokinase-type
plasminogen activator receptor (uPAR) has now firmly established itself as a versatile …

[HTML][HTML] Role of urokinase receptor in tumor progression and development

H Noh, S Hong, S Huang - Theranostics, 2013 - ncbi.nlm.nih.gov
Elevated level of urokinase receptor (uPAR) is detected in various aggressive cancer types
and is closely associated with poor prognosis of cancers. Binding of uPA to uPAR triggers …

The urokinase receptor: a multifunctional receptor in cancer cell biology. therapeutic implications

A Li Santi, F Napolitano, N Montuori… - International journal of …, 2021 - mdpi.com
Proteolysis is a key event in several biological processes; proteolysis must be tightly
controlled because its improper activation leads to dramatic consequences. Deregulation of …

Therapeutic strategies targeting urokinase and its receptor in cancer

MT Masucci, M Minopoli, G Di Carluccio, ML Motti… - Cancers, 2022 - mdpi.com
Simple Summary The uPA/uPAR system is highly involved in cancer progression and
metastasis. Many studies have definitively assessed that the high expression of urokinase …

Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors

CD Mauro, A Pesapane, L Formisano, R Rosa… - Scientific reports, 2017 - nature.com
The urokinase-type plasminogen activator receptor (uPAR) is a GPI-anchored cell
membrane receptor that focuses urokinase (uPA) proteolytic activity on the cell surface. Its …